Hans O. Andersson

448 total citations
8 papers, 368 citations indexed

About

Hans O. Andersson is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Hans O. Andersson has authored 8 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Virology and 4 papers in Molecular Biology. Recurrent topics in Hans O. Andersson's work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and Biochemical and Molecular Research (2 papers). Hans O. Andersson is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and Biochemical and Molecular Research (2 papers). Hans O. Andersson collaborates with scholars based in Sweden and United States. Hans O. Andersson's co-authors include Torsten Unge, Jimmy Lindberg, Anders Hallberg, Björn Classon, U. Helena Danielson, K. Fridborg, Göran Ahlsén, Hong Zhang, Christer Sahlberg and Snævar Sigurðsson and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and European Journal of Biochemistry.

In The Last Decade

Hans O. Andersson

8 papers receiving 360 citations

Peers

Hans O. Andersson
Janet C. Lynn United States
Chih Y. Ho United States
Suhman Chung United States
Stephen A. Fakhoury United States
Hans O. Andersson
Citations per year, relative to Hans O. Andersson Hans O. Andersson (= 1×) peers Damien Marchand

Countries citing papers authored by Hans O. Andersson

Since Specialization
Citations

This map shows the geographic impact of Hans O. Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans O. Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans O. Andersson more than expected).

Fields of papers citing papers by Hans O. Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans O. Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans O. Andersson. The network helps show where Hans O. Andersson may publish in the future.

Co-authorship network of co-authors of Hans O. Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Hans O. Andersson. A scholar is included among the top collaborators of Hans O. Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans O. Andersson. Hans O. Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Andersson, Hans O., et al.. (2003). Purification and partial characterization by matrix-assisted laser desorption ionization time-of-flight mass spectrometry of the recombinant transposase, TniA. Journal of Chromatography A. 1009(1-2). 179–188. 6 indexed citations
2.
Tedebark, Ulf, Hans O. Andersson, Devapriya Choudhury, et al.. (2003). Structure‐based discovery of a new affinity ligand to pancreatic α‐amylase. Journal of Molecular Recognition. 16(6). 396–405. 14 indexed citations
3.
Andersson, Hans O., K. Fridborg, Mathias Alterman, et al.. (2003). Optimization of P1–P3 groups in symmetric and asymmetric HIV‐1 protease inhibitors. European Journal of Biochemistry. 270(8). 1746–1758. 34 indexed citations
4.
Lindberg, Jimmy, Snævar Sigurðsson, Hans O. Andersson, et al.. (2002). Structural basis for the inhibitory efficacy of efavirenz (DMP‐266), MSC194 and PNU142721 towards the HIV‐1 RT K103N mutant. European Journal of Biochemistry. 269(6). 1670–1677. 117 indexed citations
5.
Schaal, Wesley, Anna Karlsson, Göran Ahlsén, et al.. (2000). Synthesis and Comparative Molecular Field Analysis (CoMFA) of Symmetric and Nonsymmetric Cyclic Sulfamide HIV-1 Protease Inhibitors. Journal of Medicinal Chemistry. 44(2). 155–169. 82 indexed citations
6.
Hultén, Johan, Hans O. Andersson, Wesley Schaal, et al.. (1999). Inhibitors of the C2-Symmetric HIV-1 Protease:  Nonsymmetric Binding of a Symmetric Cyclic Sulfamide with Ketoxime Groups in the P2/P2‘ Side Chains. Journal of Medicinal Chemistry. 42(20). 4054–4061. 44 indexed citations
7.
Alterman, Mathias, Hans O. Andersson, Neeraj Garg, et al.. (1999). Design and Fast Synthesis of C-Terminal Duplicated PotentC2-Symmetric P1/P1‘-Modified HIV-1 Protease Inhibitors. Journal of Medicinal Chemistry. 42(19). 3835–3844. 63 indexed citations
8.
Böttiger, D, et al.. (1997). Reverse Transcriptase and Corresponding Activity-Blocking Antibody for Monitoring SIV Infection in Macaques. AIDS Research and Human Retroviruses. 13(7). 601–610. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026